Finally, by immunoblotting and flow cytometry, they demonstrated that phosphorylation of BCR-ABL1 is fostered in AQP5-overexpressing CML cells and reduced in AQP5 siRNA-treated CML cells. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.